Biocardia issued new u.s. patent for technology that enhances control for interventional catheter based therapies

Technology anticipated to impact cardiac biologic therapies, transseptal cardiac procedures, and other interventional catheter based therapies technology anticipated to impact cardiac biologic therapies, transseptal cardiac procedures, and other interventional catheter based therapies
BCDA Ratings Summary
BCDA Quant Ranking